Employee and Directors Stock Option Plans —The 2011 Director Stock Option Plan was approved by SunLink’s shareholders at the Annual Meeting of Shareholders on November 7, 2011. This plan permits the grant of options to non-employee directors of SunLink for the purchase of up to 300,000 common shares through November 2021. Options for 50,000 shares were granted during the fiscal year ended June 30, 2020 and no options were granted during the fiscal year ended June 30, 2019. No options have been exercised under this plan. Options outstanding under the plan were 300,000 shares at June 30, 2020.

The 2005 Equity Incentive Plan approved by SunLink’s shareholders on November 7, 2005 permitted the grant of options to employees, non-employee directors and service providers of SunLink for the purchase of up to 800,000 common shares plus the number of unused shares under its 2001 Plans, which were 30,675. No options have been exercised under this Plan. No option shares were granted during the fiscal years ended June 30, 2020 and 2019, respectively. Options for 165,000 shares were forfeited during the fiscal year ended June 30, 2020. Options outstanding under this Plan were 180,000 at June 30, 2020. No additional awards may be granted under this Plan.

	Number of Shares			Weighted- Average Exercise Price		Range of Exercise Prices
Options outstanding June 30, 2018		651,000		$	1.52	$0.71 - $2.51
Granted		0		N/A		N/A
Forfeited		(56,000	)		1.46	$0.71 - $2.51
Options outstanding June 30, 2019		595,000		$	1.53	$0.71 - $2.09
Granted		50,000		1.38		1.38
Forfeited		(165,000	)		2.01	$1.79 - $2.09
Options outstanding June 30, 2020		480,000		$	1.35	$0.71 - $1.79
Options exercisable June 30, 2019		595,000		$	1.52	$0.71 - $2.51
Options exercisable June 30, 2020		480,000		$	1.35	$0.71 - $1.79

For the fiscal years ended June 30, 2020 and 2019, the Company recognized $28 and $1, respectively, of compensation expense for share options issued. As of June 30, 2020, there was no unrecognized compensation cost related to nonvested share-based compensation arrangements granted under the Plans.

Information with respect to stock options outstanding and exercisable at June 30, 2020 is as follows:

Exercise Prices		Number Outstanding		Weighted-Average Remaining Contractual Life (in years)		Number Exercisable
$	0.71		15,000		3.21		15,000
$	1.21		60,000		6.21		60,000
$	1.22		190,000		2.18		190,000
$	1.38		50,000		9.20		50,000
$	1.49		90,000		4.18		90,000
$	1.67		50,000		1.36		50,000
$	1.79		25,000		5.20		25,000
			480,000		3.90		480,000

No options were exercised during the years ended June 30, 2020 and 2019. As of June 30, 2020, and 2019, the aggregate intrinsic value of options outstanding and options exercisable were $132 and $74, respectively.

2019-2020 Common Share Repurchase Program – On October 8, 2019, the Company announced a share repurchase program (“2019-2020 Program”) approved by its Board of Directors which authorized the Company to purchase up to $750 of its common shares in the open market. On March 24, 2020, the Company announced that it had suspended the 2019-2020 Program in light of the COVID-19 pandemic and on June 1, 2020, the Company terminated the 2019-2020 program. The total number of shares that have been purchased under the Plan is 87,534 and the cost of such shares was approximately $101. The chart below shows by month the total shares repurchased and average price per share paid for the 2019-2020 Program.

	Total Shares		Average Price
	Purchased		Per Share Paid
November 2019		935	$	1.17
December 2019		2,879		1.18
January 2020		4,272		1.15
February 2020		33,873		1.22
March 2020		45,575		1.09
Total		87,534	$	1.15

2018 Common Share Repurchase Program – On November 29, 2018, the Company announced a share repurchase program (“2018 Program”) approved by its Board of Directors, which authorized the Company to purchase up to 300,000 shares of its common shares. On December 13, 2018, the Company announced it had purchased the 300,000 shares authorized under the program, and that its Board of Directors had authorized an additional 450,000 shares to be purchased under the 2018 Program. The total number of shares that was purchased under the 2018 Program was 359,959 and the cost of shares purchased was approximately $372. The chart below shows by month the total shares repurchased and average price per share paid for the 2018 Program prior to its termination.

	Total Shares		Average Price
	Purchased		Per Share Paid
November 2018		1,235	$	1.14
December 2018		358,724		1.03
Total		359,959	$	1.03

Accumulated Other Comprehensive Loss —Information with respect to the balances of each classification within accumulated other comprehensive loss is as follows:

	Minimum Pension Liability Adjustment			Accumulated Other Comprehensive Loss
June 30, 2018	$	(177	)	$	(177	)
Current period change		(76	)		(76	)
June 30, 2019	$	(253	)	$	(253	)
Current period change		(86	)		(86	)
June 30, 2020	$	(339	)	$	(339	)